Literature DB >> 11489511

Sterically stabilized polyplex: ligand-mediated activity.

M C Woodle1, P Scaria, S Ganesh, K Subramanian, R Titmas, C Cheng, J Yang, Y Pan, K Weng, C Gu, S Torkelson.   

Abstract

Synthetic vectors have been considered as a safer and more versatile alternative to viral-based gene delivery systems. A variety of very simple synthetic vector systems, e.g., cationic lipid- and polymer-complexed plasmid DNA have activity in vivo but it appears to be mediated by non-specific electrostatic interactions limiting targeting. In order to avoid these problems, we designed a sterically stabilized layered colloidal system. The steric polymer coating reduces non-specific interactions. We have synthesized a PEG conjugate of PEI that complexes DNA to form small, stable colloids with a steric polymer coat on their surface. The polymer enhances colloidal stability and reduces non-specific binding and toxicity. It also renders the complex inactive presumably due to reduced binding. Ligands are then appended to the distal end of the steric polymer to restore cell binding and expression at target cells. We prepared conjugates with RGD peptide ligands appended to the distal end of the steric polymer. The resulting conjugates also form complexes but with ligands exposed on their surface restoring binding and activity. Labeled oligonucleotides and DNA were used to measure intracellular distribution. Oligonucleotides are found localized in the nucleus, whereas the labeled plasmid DNA remained in the cytoplasm. Import of plasmid DNA into the nucleus appears to be very inefficient yet sufficient for expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11489511     DOI: 10.1016/s0168-3659(01)00339-x

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  12 in total

Review 1.  Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.

Authors:  Long Xu; Thomas Anchordoquy
Journal:  J Pharm Sci       Date:  2011-01       Impact factor: 3.534

2.  Effect of cholesterol nanodomains on the targeting of lipid-based gene delivery in cultured cells.

Authors:  Long Xu; Thomas J Anchordoquy
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

3.  Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle.

Authors:  Raymond M Schiffelers; Aslam Ansari; Jun Xu; Qin Zhou; Qingquan Tang; Gert Storm; Grietje Molema; Patrick Y Lu; Puthupparampil V Scaria; Martin C Woodle
Journal:  Nucleic Acids Res       Date:  2004-11-01       Impact factor: 16.971

4.  Targeted delivery of a splice-switching oligonucleotide by cationic polyplexes of RGD-oligonucleotide conjugate.

Authors:  Xin Ming; Lan Feng
Journal:  Mol Pharm       Date:  2012-04-25       Impact factor: 4.939

5.  Surface functionalized cationic lipid-DNA complexes for gene delivery: PEGylated lamellar complexes exhibit distinct DNA-DNA interaction regimes.

Authors:  Ana Martin-Herranz; Ayesha Ahmad; Heather M Evans; Kai Ewert; Uwe Schulze; Cyrus R Safinya
Journal:  Biophys J       Date:  2004-02       Impact factor: 4.033

6.  Integrin targeted delivery of gene therapeutics.

Authors:  Rudy L Juliano; Xin Ming; Osamu Nakagawa; Rongzuo Xu; Hoon Yoo
Journal:  Theranostics       Date:  2011-03-02       Impact factor: 11.556

Review 7.  Inhaled chemotherapy in lung cancer: future concept of nanomedicine.

Authors:  Paul Zarogoulidis; Ekaterini Chatzaki; Konstantinos Porpodis; Kalliopi Domvri; Wolfgang Hohenforst-Schmidt; Eugene P Goldberg; Nikos Karamanos; Konstantinos Zarogoulidis
Journal:  Int J Nanomedicine       Date:  2012-03-22

8.  Evaluation of copolymers of N-isopropylacrylamide and 2-dimethyl(aminoethyl)methacrylate in nonviral and adenoviral vectors for gene delivery to nasopharyngeal carcinoma.

Authors:  Jim Moselhy; Swapna Sarkar; Maria C Chia; Joseph D Mocanu; Nicolas Taulier; Fei-Fei Liu; Xiao Yu Wu
Journal:  Int J Nanomedicine       Date:  2007

9.  Targeted delivery of let-7a microRNA encapsulated ephrin-A1 conjugated liposomal nanoparticles inhibit tumor growth in lung cancer.

Authors:  Hung-Yen Lee; Kamal A Mohammed; Fredric Kaye; Parvesh Sharma; Brij M Moudgil; William L Clapp; Najmunnisa Nasreen
Journal:  Int J Nanomedicine       Date:  2013-11-21

Review 10.  Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers.

Authors:  Md Emranul Karim; Kyi Kyi Tha; Iekhsan Othman; Mohammad Borhan Uddin; Ezharul Hoque Chowdhury
Journal:  Pharmaceutics       Date:  2018-05-26       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.